Catalyst Wire Dossier Catalyst Wire Dossier

Xigris (drotrecogin alfa activated)

drotrecogin alfa activated · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Xigris (drotrecogin alfa activated), covering 2016-07-26 to 2016-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Activated Protein C in Acute Stroke Trial [Phase 2]

See pricing